Market Overview

Tuesday's Top 6 Pre-Market Gainers Explained

Tuesday's Top 6 Pre-Market Gainers Explained
  • Sarepta Therapeutics Inc (NASDAQ: SRPT) was up 28.97 percent after the FDA requested Dystrophin data prior to making a decision on Eteplirsen NDA in addition to Wedbush upgrading the company to Outperform with a price target of $36.00.
  • United Natural Foods, Inc. (NASDAQ: UNFI) rose 10.74 percent following its better-than-expected earnings for its third quarter and raised 2016 FY16 outlook.
  • Zillow Group, Inc.-Class A (NASDAQ: ZG) jumped 10.45 percent after Barclays upgraded Zillow to Neutral following Zillow paying $130 million to settle News Corp (NASDAQ: NWSA)/NAR
    litigation, which originally was estimated to be at least $500 million, according to Barclays.
  • Related Link: Zillow Just Removed A "Significant Overhang"; Class A Shares Up +9% In Pre-Market

  • Tribune Publishing Co (NYSE: TPUB) traded up 1.54 percent after Gannet Co Inc (NYSE: GCI) issued a statement regarding its $15.00 per share all-cash premium offer to acquire Tribune Publishing, thanks stockholders of Tribune to withhold vote at Tribune Annual Meeting.
  • Regulus Therapeutics Inc (NASDAQ: RGLS) was trading up 4.71 percent after announcing positive top-line data on Hepatitis C virus treatment.
  • Williams Companies Inc (NYSE: WMB) rose 3.08 percent after Energy Transfer Equity LP (NYSE: ETE) reported election deadline for Williams Company.
  • Posted-In: dystrophin eteplirsen WedbushLong Ideas News Pre-Market Outlook Movers Trading Ideas


    Related Articles (ETE + GCI)

    View Comments and Join the Discussion!

    Stocks Hitting 52-Week Highs

    Mid-Morning Market Update: Markets Mostly Higher; Valeant Earnings Miss Views